Clinical Trial Update: Combination Therapy With Fludarabine, Mitoxantrone and Rituximab in Mantle Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating fludarabine, mitoxantrone, and rituximab in mantle cell lymphoma has been terminated. The study NCT00183989 is no longer ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• Fludarabine (Fludarabine)
• Mitoxantrone (mitoxantrone)
• Rituximab (rituximab)

Snippet

Sponsor: University of Southern California | Conditions: Mantle Cell Lymphoma | Phase 2 | Status: TERMINATED